glp 1 meaning diabetes GLP-1 what does glp 1 support

Between July 2023 - when Intuitive first mentioned weight loss drugs - and October 2023, medical device companies that were deemed GLP-1 losers sold off aggressively (e.g., diabetes medical devices, sleep apnea devices, bariatric surgery), while the GLP-1 companies themselves (Eli Lilly and Novo Nordisk) increased in value much more than the broader market

Mounjaro (approved 2022) is indicated for T2D, while Zepbound(approved late 2024) is indicated for chronic weight management in obese adults, including those with weight-related conditions like obstructive sleep apnea

In addition to the systematic review, members of the consensus group suggested relevant additional studies

JM was encouraged to call the clinic with any questions or concerns